# Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units

> **NCT00718744** · PHASE2 · COMPLETED · sponsor: **Laboratorios Leti, S.L.** · enrollment: 30 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Conjunctivitis, Allergic

## Interventions

- **OTHER:** Standardization of allergenic extract (Ch. arcuatus)

## Key facts

- **NCT ID:** NCT00718744
- **Lead sponsor:** Laboratorios Leti, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718744, "Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00718744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*